Is APLM or APUS more undervalued in 2026?

CirclFi compares Apollomics Inc. (APLM) and Apimeds Pharmaceuticals US, Inc (APUS) using 13 institutional-grade valuation models. APLM has a Quality of Company score of 1.8/10 while APUS scores 4.8/10.

Which is a better buy — APLM or APUS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do APLM and APUS valuations compare?

APLM at $14.15 and APUS at $1.41 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

APLM vs APUS Valuation Comparison 2026 — Intrinsic Value Analysis

APLM

Pharmaceutical Preparations

Apollomics Inc.

Quality

1.8

out of 10

Value Trap

—

Price

$14.15

Last close

Models

8/13

Active

APUS

Pharmaceutical Preparations

Apimeds Pharmaceuticals US, Inc

Quality

4.8

out of 10

Value Trap

SAFE

Price

$1.41

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	APLM Fair Value	APLM Upside	APUS Fair Value	APUS Upside
Bayesian DCF	Intrinsic	$3.73	-73.6%	$0.41	-70.8%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$7.73	-45.3%	$4.65	+230.1%
PWERM	Option-Based	$12.28	-13.2%	$2.45	+73.7%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for APLM vs APUS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

APLM vs APUS — Which Stock Is More Undervalued?

APUS scores higher with a 4.8/10 quality rating vs APLM's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Apollomics Inc. (APLM) and Apimeds Pharmaceuticals US, Inc (APUS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

APLM currently trades at $14.15 with a QOC of 1.8/10, while APUS trades at $1.41 with a QOC of 4.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).